-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 21, Guilin Sanjin issued an announcement stating that, recently, its holding company, Baochuan Biomedical Technology (Shanghai) Co.
BC006 monoclonal antibody injection is a humanized IgG1 monoclonal antibody against macrophage colony stimulating factor 1 receptor (CSF-1R, Colony Stimulating Factor 1 Receptor), which specifically targets the surface of monocyte-macrophage mesangial cells CSF-1R inhibits its dimerization and blocks the activation of downstream intracellular signaling pathways, thereby reducing the number of immunosuppressive M2-like macrophages in the tumor microenvironment, restoring the function of macrophages, and producing anti-tumor effects.